« previous next »
Pages: [1]

Author Topic: (Abst.) Incidence of MS misdiagnosis in referrals to 2 academic centers  (Read 114 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Incidence of MS misdiagnosis in referrals to 2 academic centers
« on: February 11, 2019, 02:48:54 pm »

Among 241 patients with an established MS diagnosis referred to the UCLA and Cedars Sinai medical centers, 1 in 5 was found to have been misdiagnosed, according to this study.

From PubMed, February 20, 2019


https://www.ncbi.nlm.nih.gov/pubmed/30738280
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Offline ewizabeth

  • Trailblazer
  • *
  • Posts: 596
Re: (Abst.) Incidence of MS misdiagnosis in referrals to 2 academic centers
« Reply #1 on: April 16, 2019, 07:14:14 am »
Thanks Agate. I didn't see it but I knew it was probably here somewhere.
Report to moderator   Logged

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
Re: (Abst.) Incidence of MS misdiagnosis in referrals to 2 academic centers
« Reply #2 on: April 16, 2019, 07:16:37 am »
It's good to have an "interpreted" version too. It's much easier to understand. I try to find one whenever possible but missed that one!
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics